GLIPIZIDE 2.5 MG TABLET
For 30 tablets
Pharmacies pay
$38.02 filed
30 × $1.26741 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$2.35 filed
30 × $0.07826 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.06× estimated
These two figures may not measure the same thing
At 0.06×, the Medicare figure is 0.2 times what pharmacies pay or less. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.
This product’s middle NADAC price, $1.26741 per EA, is 37.4× the middle NADAC price of the 2 other products CMS averages under “Glipizide” ($0.03388 per EA), so the Part D average may mostly describe those products, not this one.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$48.72 estimated
$38.02 + $5.70 (15%) + $5.00 fee per fill = $48.72
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
GLIPIZIDE 2.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as glipizide.
FDA gives its dosage form as tablet and its route as oral.
The labeler, the company named on the label, is TruPharma LLC.
FDA’s Established Pharmacologic Class for it is Sulfonylurea.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 52817-0385-10.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $38.02 for 30 tablets (30 × $1.26741 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 52817-0385-10 · TruPharma LLC · $1.26741 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share the FDA nonproprietary name glipizide with GLIPIZIDE 2.5 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| GLIPIZIDE 2.5 MG TABLET this page | $1.26741 per EA filed | $0.07826 per EA filed |
| GLIPIZIDE 5 MG TABLET | $0.03388 per EA filed | $0.07826 per EA filed |
| GLIPIZIDE 10 MG TABLET | $0.04476 per EA filed | $0.07826 per EA filed |
| GLIPIZIDE ER 2.5 MG TABLET | $0.09927 per EA filed | $0.15089 per EA filed |
| GLIPIZIDE ER 5 MG TABLET | $0.07375 per EA filed | $0.15089 per EA filed |
| GLIPIZIDE ER 10 MG TABLET | $0.12172 per EA filed | $0.15089 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $1.26741 per EA filed.
Of the 20 other products in FDA’s Sulfonylurea class priced per EA, 2 have a higher middle NADAC price and 18 a lower one. The one in the middle is GLIPIZIDE ER 2.5 MG TABLET, at $0.09927 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $2.35 for 30 tablets, at an average of $0.07826 per EA in 2024 (2024-01-01 to 2024-12-31) for “Glipizide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 4,523,542 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for GLIPIZIDE 2.5 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: Part D averages every strength and form sold under “Glipizide” into one figure, so it is not specific to this NDC. The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Glipizide / Glipizide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- GLIMEPIRIDE 1 MG TABLET
- GLIPIZIDE-METFORMIN 2.5-250 MG
- GLYBURIDE 1.25 MG TABLET
- GLYBURIDE-METFORMIN 2.5-500 MG
- PIOGLITAZONE-GLIMEPIRIDE 30-2